Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Sternberg

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|April 11, 2025
Exposure-Response Relationships in Patients with Non-Small-Cell Lung Cancer and Other Solid Tumors Treated with Patritumab Deruxtecan (HER3-DXd)Li Li, Mark Lee, Rujuta Joshi, et al.
Journal of Addiction Medicine|February 9, 2021
Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C TreatmentKristi Hill, Laura Nussdorf, Julia D Mount, et al.
Open Forum Infectious Diseases|October 13, 2022
PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCVKristi C Hill, Sarah M Kattakuzhy, Rachel Silk, et al.
Advances in Therapy|July 3, 2024
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based ChemotherapyJyoti Patel, Jie Meng, Hoa Le, et al.
Open Forum Infectious Diseases|December 16, 2024
High Rates of High-risk HPV Anal Infection and Abnormal Cytology in a Cohort of Transgender People Assigned Male at BirthOmar Harfouch, Andrea Lisco, Habib Omari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2020
Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject DrugsElana S Rosenthal, Rachel Silk, Poonam Mathur, et al.
AIDS Patient Care and Stds|January 27, 2025
A Sequential Mixed-Methods Study of Factors Associated with Low High-Resolution Anoscopy Completion in Transgender Women with Abnormal Anal CytologyOmar Harfouch, Darren Whitfield, Tural Mammadli, et al.
Journal of Virological Methods|February 15, 2026
Comparison of Whole-Viral Genome Sequencing and PCR-based assay for Anal HPV Detection to Inform Clinical ImplementationOmar Harfouch, Derek MacMath, Poorani Subramanian, et al.
Open Forum Infectious Diseases|February 21, 2022
Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus TreatmentChristopher Brokus, Sarah Kattakuzhy, Britt Gayle, et al.
Cancer Discovery|September 22, 2021
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, <i>EGFR</i>-Mutated Non-Small Cell Lung CancerPasi A Jänne, Christina Baik, Wu-Chou Su, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|April 11, 2025
Exposure-Response Relationships in Patients with Non-Small-Cell Lung Cancer and Other Solid Tumors Treated with Patritumab Deruxtecan (HER3-DXd)Li Li, Mark Lee, Rujuta Joshi, et al.
Journal of Addiction Medicine|February 9, 2021
Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C TreatmentKristi Hill, Laura Nussdorf, Julia D Mount, et al.
Open Forum Infectious Diseases|October 13, 2022
PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCVKristi C Hill, Sarah M Kattakuzhy, Rachel Silk, et al.
Advances in Therapy|July 3, 2024
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based ChemotherapyJyoti Patel, Jie Meng, Hoa Le, et al.
Open Forum Infectious Diseases|December 16, 2024
High Rates of High-risk HPV Anal Infection and Abnormal Cytology in a Cohort of Transgender People Assigned Male at BirthOmar Harfouch, Andrea Lisco, Habib Omari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2020
Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject DrugsElana S Rosenthal, Rachel Silk, Poonam Mathur, et al.
AIDS Patient Care and Stds|January 27, 2025
A Sequential Mixed-Methods Study of Factors Associated with Low High-Resolution Anoscopy Completion in Transgender Women with Abnormal Anal CytologyOmar Harfouch, Darren Whitfield, Tural Mammadli, et al.
Journal of Virological Methods|February 15, 2026
Comparison of Whole-Viral Genome Sequencing and PCR-based assay for Anal HPV Detection to Inform Clinical ImplementationOmar Harfouch, Derek MacMath, Poorani Subramanian, et al.
Open Forum Infectious Diseases|February 21, 2022
Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus TreatmentChristopher Brokus, Sarah Kattakuzhy, Britt Gayle, et al.
Cancer Discovery|September 22, 2021
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, <i>EGFR</i>-Mutated Non-Small Cell Lung CancerPasi A Jänne, Christina Baik, Wu-Chou Su, et al.
Pageof 3